Cohance Lifesciences Limited — Others, 18-12-2024: Shareholders meeting

Suven Pharmaceuticals Limited's recent postal ballot results revealed strong shareholder support for key appointments. Mr. Vivek Sharma has been appointed as Executive Chairman and Director, alongside Mr. Jai Shankar Krishnan as an Independent Director, and Mr. Vinod Padikkal as a Non-Executive and Non-Independent Director. Each resolution passed with overwhelming majorities: Sharma's appointment received 88.49% in favor, Krishnan's 99.99%, and Padikkal's 99.81%. This successful outcome could instill investor confidence and position the company favorably for future growth initiatives, suggesting a positive outlook for shareholders.